 | Hetero's Tocilizumab biosimilar gets emergency use authorisation from DCGI for COVID treatmentHetero's biologics arm, Hetero Biopharma will manufacture the drug at its dedicated biologics facility, based at Jadcherla in Hyderabad. |
 | Zydus Cadila's Covid vaccine gets approval, to be administered to children in IndiaThis is the world's first DNA-based vaccine against the coronavirus, and this three-dose vaccine when injected produces the spike protein of the SARS-CoV-2 virus and elicits an immune response. |
 | Pfizer, Johnson and Johnson yet to apply for license of COVID-19 vaccines in India: SourcesAnother giant pharma company Moderna is supposed to donate seven million doses to India from the United States under Covax is still pending. |
 | 'India to make 850 millon Sputnik doses annually': Vaccine makers lay out production plans after getting DGCI approvalThe Drug Controller General of India (DCGI) has registered the vaccine under the emergency use authorisation procedure. |
 | Indian government may blacklist eight Chinese pharma firms over quality issuesSources said that with government's action against the China firms, India may witness a shortage of medicines, including for vital diseases such as cancer, for a couple of months. |
